MSF: Gilead must do more to make lifesaving drug widely available for people with HIV
As Gilead Sciences held its annual stockholders’ meeting yesterday, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) called on the US pharmaceutical corporation to finally fulfill its 2018 promise and ensure that the lifesaving drug liposomal amphotericin B (L-AmB, marketed as Ambisome) is more widely available for people with HIV who also…